DrugPatentWatch Database Preview
ENBREL Drug Profile
Summary for Tradename: ENBREL
| Patents: | 288 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 2 |
| Drug Prices: | Drug price information for ENBREL |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ENBREL |
Pharmacology for ENBREL
| Mechanism of Action | Tumor Necrosis Factor Receptor Blocking Activity |
US Patents for ENBREL
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunex | ENBREL | etanercept | SYRINGE | 103795 | 002 | 1998-11-02 | ➤ Try a Free Trial | TACT IP, LLC (Highland Beach, FL) | ➤ Try a Free Trial | RX | Orphan | search |
| Immunex | ENBREL | etanercept | SYRINGE | 103795 | 002 | 1998-11-02 | ➤ Try a Free Trial | Immunex Corporation (Seattle, WA) | ➤ Try a Free Trial | RX | Orphan | company |
| Immunex | ENBREL | etanercept | SYRINGE | 103795 | 002 | 1998-11-02 | ➤ Try a Free Trial | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Try a Free Trial | RX | Orphan | search |
| Immunex | ENBREL | etanercept | SYRINGE | 103795 | 002 | 1998-11-02 | ➤ Try a Free Trial | CARDIONOVUM Sp.z.o.o. (Warsaw, PL) | ➤ Try a Free Trial | RX | Orphan | search |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for ENBREL
| Country | Document Number | Estimated Expiration |
|---|---|---|
| United Kingdom | 201315737 | ➤ Try a Free Trial |
| Eurasian Patent Organization | 201400182 | ➤ Try a Free Trial |
| Japan | 5781514 | ➤ Try a Free Trial |
| Australia | 2006200981 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for ENBREL
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB10/044 | United Kingdom | ➤ Try a Free Trial | PRODUCT NAME: DENOSUMAB, IMMUNOGLOBULIN G2, ANTI-(HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 11 (HUMAN OSTEOCLAST DIFFERENTIATION FACTOR)) HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER.; REGISTERED: UK EU/1/10/618/001 20100526; UK EU/1/10/618/002 20100526; UK EU/1/10/618/003 20100526; UK EU/1/10/618/004 20100526 |
| 00728 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: IBRUTINIB OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/14/945 20141021 |
| 2015 00021 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: IBRUTINIB ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/14/945 20141023 |
| C0050 | France | ➤ Try a Free Trial | PRODUCT NAME: DENOSUMAB; REGISTRATION NO/DATE IN FRANCE: EU/1/10/618/001 DU 20100526; REGISTRATION NO/DATE AT EEC: EU/1/10/618/001-004 DU 26-05- |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
